Noopur Raje, MD

Articles by Noopur Raje, MD

Quadruplet Vs Triplet Induction Regimens for Transplant-Eligible NDMM

ByNoopur Raje, MD,Jacob Laubach, MD,Omar Nadeem, MD,Andrew J. Yee, MD

June 15th 2022

Shared insight on approved quadruplet vs triplet induction regimens for patients with transplant-eligible, newly diagnosed multiple myeloma, evaluated in the GRIFFIN, MASTER and GMMG-HD7 trials.

Patient Profile 1: A 62-Year-Old With Transplant-Eligible NDMM

ByNoopur Raje, MD,Jacob Laubach, MD,Omar Nadeem, MD,Andrew J. Yee, MD

June 15th 2022

Experts discuss a patient with transplant-eligible, newly diagnosed multiple myeloma managed with induction daratumumab-RVd and maintenance therapy.

New Developments in Multiple Myeloma

ByNoopur Raje, MD

December 8th 2014

In this podcast from the 2014 American Society of Hematology Annual Meeting, we discuss some of the new developments in multiple myeloma.

Noopur Raje, MD

Articles by Noopur Raje, MD

Quadruplet Vs Triplet Induction Regimens for Transplant-Eligible NDMM

Patient Profile 1: A 62-Year-Old With Transplant-Eligible NDMM

New Developments in Multiple Myeloma

Trending on CancerNetwork

All-Oral Revumenib Regimen May Show Advantage in Newly Diagnosed AML

Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma

Blinatumomab/Ponatinib Provides Chemo-Free Option in Ph+ ALL

Azacitidine Plus Venetoclax Improves EFS in Acute Myeloid Leukemia

Gintemetostat Has Single-Agent Activity in Pretreated R/R Multiple Myeloma